BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31769792)

  • 1. Low-Grade Ductal Carcinoma In Situ.
    Alghamdi SA; Krishnamurthy K; Garces Narvaez SA; Algashaamy KJ; Aoun J; Reis IM; Recine MA; Jorda M; Poppiti RJ; Gomez-Fernandez CR
    Am J Clin Pathol; 2020 Feb; 153(3):360-367. PubMed ID: 31769792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.
    Van Bockstal M; Baldewijns M; Colpaert C; Dano H; Floris G; Galant C; Lambein K; Peeters D; Van Renterghem S; Van Rompuy AS; Verbeke S; Verschuere S; Van Dorpe J
    Histopathology; 2018 Dec; 73(6):923-932. PubMed ID: 30168167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic challenge of low-grade ductal carcinoma in situ.
    Onega T; Weaver DL; Frederick PD; Allison KH; Tosteson ANA; Carney PA; Geller BM; Longton GM; Nelson HD; Oster NV; Pepe MS; Elmore JG
    Eur J Cancer; 2017 Jul; 80():39-47. PubMed ID: 28535496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in grading of ductal carcinoma in situ among an international group of pathologists.
    van Seijen M; Jóźwiak K; Pinder SE; Hall A; Krishnamurthy S; Thomas JS; Collins LC; Bijron J; Bart J; Cohen D; Ng W; Bouybayoune I; Stobart H; Hudecek J; Schaapveld M; Thompson A; Lips EH; Wesseling J;
    J Pathol Clin Res; 2021 May; 7(3):233-242. PubMed ID: 33620141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
    Gomes DS; Porto SS; Balabram D; Gobbi H
    Diagn Pathol; 2014 Jun; 9():121. PubMed ID: 24948027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
    Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep learning-based grading of ductal carcinoma in situ in breast histopathology images.
    Wetstein SC; Stathonikos N; Pluim JPW; Heng YJ; Ter Hoeve ND; Vreuls CPH; van Diest PJ; Veta M
    Lab Invest; 2021 Apr; 101(4):525-533. PubMed ID: 33608619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ.
    Sneige N; Lagios MD; Schwarting R; Colburn W; Atkinson E; Weber D; Sahin A; Kemp B; Hoque A; Risin S; Sabichi A; Boone C; Dhingra K; Kelloff G; Lippman S
    Hum Pathol; 1999 Mar; 30(3):257-62. PubMed ID: 10088542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological grading of breast ductal carcinoma in situ: validation of a web-based survey through intra-observer reproducibility analysis.
    Schuh F; Biazús JV; Resetkova E; Benfica CZ; Ventura Ade F; Uchoa D; Graudenz M; Edelweiss MI
    Diagn Pathol; 2015 Jul; 10():93. PubMed ID: 26159429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma In Situ.
    Tozbikian G; Brogi E; Vallejo CE; Giri D; Murray M; Catalano J; Olcese C; Van Zee KJ; Wen HY
    Int J Surg Pathol; 2017 Apr; 25(2):100-107. PubMed ID: 27481892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes.
    Singh K; Paquette C; Kalife ET; Wang Y; Mangray S; Quddus MR; Steinhoff MM
    Hum Pathol; 2018 Aug; 78():163-170. PubMed ID: 29753007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study.
    Tsuda H; Yoshida M; Akiyama F; Ohi Y; Kinowaki K; Kumaki N; Kondo Y; Saito A; Sasaki E; Nishimura R; Fujii S; Homma K; Horii R; Murata Y; Itami M; Kajita S; Kato H; Kurosumi M; Sakatani T; Shimizu S; Taniguchi K; Tamiya S; Nakamura H; Kanbayashi C; Shien T; Iwata H
    Jpn J Clin Oncol; 2021 Mar; 51(3):434-443. PubMed ID: 33420502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of Papillary Breast Lesions on Core Needle Biopsy: Upgrade Rates and Interobserver Variability.
    Qiu L; Mais DD; Nicolas M; Nanyes J; Kist K; Nazarullah A
    Int J Surg Pathol; 2019 Oct; 27(7):736-743. PubMed ID: 31187678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey.
    Schuh F; Biazús JV; Resetkova E; Benfica CZ; Edelweiss MI
    Pathol Res Pract; 2010 Oct; 206(10):705-11. PubMed ID: 20663616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic concordance among pathologists interpreting breast biopsy specimens.
    Elmore JG; Longton GM; Carney PA; Geller BM; Onega T; Tosteson AN; Nelson HD; Pepe MS; Allison KH; Schnitt SJ; O'Malley FP; Weaver DL
    JAMA; 2015 Mar; 313(11):1122-32. PubMed ID: 25781441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study.
    Elmore JG; Tosteson AN; Pepe MS; Longton GM; Nelson HD; Geller B; Carney PA; Onega T; Allison KH; Jackson SL; Weaver DL
    BMJ; 2016 Jun; 353():i3069. PubMed ID: 27334105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interobserver Variability in Ductal Carcinoma In Situ of the Breast.
    Van Bockstal MR; Berlière M; Duhoux FP; Galant C
    Am J Clin Pathol; 2020 Oct; 154(5):596-609. PubMed ID: 32566938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologists' agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes.
    Wells WA; Carney PA; Eliassen MS; Grove MR; Tosteson AN
    Am J Surg Pathol; 2000 May; 24(5):651-9. PubMed ID: 10800983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grading Ductal Carcinoma In Situ (DCIS) of the Breast - What's Wrong with It?
    Cserni G; Sejben A
    Pathol Oncol Res; 2020 Apr; 26(2):665-671. PubMed ID: 31776839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grading variation in 2,934 patients with ductal carcinoma in situ of the breast: the effect of laboratory- and pathologist-specific feedback reports.
    van Dooijeweert C; van Diest PJ; Baas IO; van der Wall E; Deckers IAG
    Diagn Pathol; 2020 May; 15(1):52. PubMed ID: 32393303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.